These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29930889)

  • 1. Post Vaccination Guillain Barre Syndrome: A Case Report.
    Wajih Ullah M; Qaseem A; Amray A
    Cureus; 2018 Apr; 10(4):e2511. PubMed ID: 29930889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barre syndrome occurring after rabies vaccination.
    Siddiqui A; Usmani RI; Anwer S; Afsar S
    J Pak Med Assoc; 2005 Feb; 55(2):87-8. PubMed ID: 15813639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series.
    Nagdev G; Chavan G; Sahu G; Devasilpa Raju PD
    Cureus; 2022 Oct; 14(10):e30888. PubMed ID: 36465787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
    Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
    Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines and Guillain-Barré syndrome.
    Haber P; Sejvar J; Mikaeloff Y; DeStefano F
    Drug Saf; 2009; 32(4):309-23. PubMed ID: 19388722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe.
    Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M;
    BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
    Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA
    JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.
    Kim JE; Park J; Min YG; Hong YH; Song TJ
    J Peripher Nerv Syst; 2022 Sep; 27(3):206-214. PubMed ID: 35751472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
    Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
    Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine-preventable diseases, vaccines and Guillain-Barre' syndrome.
    Principi N; Esposito S
    Vaccine; 2019 Sep; 37(37):5544-5550. PubMed ID: 29880241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
    Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
    N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database.
    Keh RYS; Scanlon S; Datta-Nemdharry P; Donegan K; Cavanagh S; Foster M; Skelland D; Palmer J; Machado PM; Keddie S; Carr AS; Lunn MP;
    Brain; 2023 Feb; 146(2):739-748. PubMed ID: 35180300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
    Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
    Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States.
    Ojha RP; Jackson BE; Tota JE; Offutt-Powell TN; Singh KP; Bae S
    Hum Vaccin Immunother; 2014; 10(1):232-7. PubMed ID: 24013368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guillain-Barré syndrome--a classical autoimmune disease triggered by infection or vaccination.
    Israeli E; Agmon-Levin N; Blank M; Chapman J; Shoenfeld Y
    Clin Rev Allergy Immunol; 2012 Apr; 42(2):121-30. PubMed ID: 20890797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.
    Biswas A; Pandey SK; Kumar D; Vardhan H
    Indian J Public Health; 2021; 65(4):422-424. PubMed ID: 34975092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear.
    Babazadeh A; Mohseni Afshar Z; Javanian M; Mohammadnia-Afrouzi M; Karkhah A; Masrour-Roudsari J; Sabbagh P; Koppolu V; Vasigala VK; Ebrahimpour S
    J Transl Int Med; 2019 Dec; 7(4):137-142. PubMed ID: 32010599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-Campylobacter Guillain Barré Syndrome in the USA: secondary analysis of surveillance data collected during the 2009-2010 novel Influenza A (H1N1) vaccination campaign.
    Halpin AL; Gu W; Wise ME; Sejvar JJ; Hoekstra RM; Mahon BE
    Epidemiol Infect; 2018 Oct; 146(13):1740-1745. PubMed ID: 29986777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.